Pyrimidine metabolism

From Wikipedia, the free encyclopedia
  (Redirected from Pyrimidine synthesis inhibitor)
Jump to: navigation, search

Pyrimidine biosynthesis occurs both in the body and through organic synthesis.

Contents

[edit] De novo biosynthesis of pyrimidine

|- 
|  carbamoyl phosphate synthetase II[1] || carbamoyl phosphate || This is the regulated step in the pyrimidine biosynthesis. 
|- 
| aspartic transcarbamolyase (aspartate carbamoyl transferase)[2] || carbamoyl aspartic acid || -
|- 
| dihhydroorotase[3] || dihydroorotate || Dehydration 
|- 
| dihydroorotate dehydrogenase[4] (the only mitochondrial enzyme) || orotate || Dihydroorotate then enters the mitochondria where it is oxidised through removal of hydrogens. This is the only mitochondrial step in nucleotide rings biosynthesis. 
|- 
| orotate phosphoribosyltransferase[5] || OMP  || PRPP is used.
|- 
| OMP decarboxylase[6] || UMP || Decarboxylation
|- 
| uridine-cytidine kinase 2[7]  || UDP || Phosphorylation. ATP is used.
|- 
| nucleoside diphosphate kinase ||  UTP || Phosphorylation. ATP is used.
|- 
|  CTP synthase ||  CTP || Glutamine and ATP are used.

|}

The first three enzymes are all coded by the same gene in Metazoa (CAD). In Fungi, a similar protein exists but lacks the dihydroorotase function: another protein catalyzes the second step.

In other organisms (Bacteria, Archaea and the other Eukaryota), the first three steps are done by three different enzymes.

[edit] Pyrimidine catabolism

Pyrimidines are ultimately catabolized (degraded) to CO2, H2O, and urea. Cytosine can be broken down to uracil which can be further broken down to N-carbamoyl-β-alanine. Thymine is broken down into β-aminoisobutyrate which can be further broken down into intermediates eventually leading into the citric acid cycle.

β-aminoisobutyrate acts as a rough indicator for rate of DNA turnover.[citation needed]

[edit] Pharmacotherapy

Modulating the pyrimidine metabolism pharmacologically has therapeutical uses.

Pyrimidine synthesis inhibitors are used in active moderate to severe rheumatoid arthritis and psoriatic arthritis. Examples include Leflunomide and Teriflunomide.

[edit] References

[edit] External links

Personal tools
Namespaces

Variants
Actions
Navigation
Interaction
Toolbox
Print/export
Languages